NCT06384755

Brief Summary

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2024Dec 2026

Study Start

First participant enrolled

April 20, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

May 2, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

April 22, 2024

Last Update Submit

April 30, 2024

Conditions

Keywords

Honest Open Proud programPsychotic and Bipolar disorders

Outcome Measures

Primary Outcomes (1)

  • Stigma Stress Scale (Rüsch, Corrigan, Wassel et al., 2009; Rüsch, Corrigan, Powell et al., 2009)

    8 items, from 1 (strongly disagree) to 7 (strongly agree)

    Change from T0 to T1 and T2 (assessed at T0 = week 0; T1 =week 3; T2 = week 6)

Secondary Outcomes (7)

  • Disclosure Distress (Rüsch et al., 2014a)

    Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)

  • Warwick and Edinburgh Wellbeing Scale (WEMWBS) (Tennant et al 2007)

    Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)

  • Satisfaction with life (Lehman, 1988)

    Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)

  • The Questionnaire about the Process of Recovery - 15 (QPR-15) (Niel et al 2007)

    Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)

  • Internalised Stigma of Mental Illness Inventory (ISMI-10) (Boyd, Otilingam, & Deforge, 2014)

    Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)

  • +2 more secondary outcomes

Other Outcomes (4)

  • Disclosure

    Assessed at T1 and T2 (T1= week 3 and T2 = week 6)

  • Feasibility of HOP program

    Tracked during trial and evaluated after completion (T2 = week 6)

  • Acceptability of HOP program participants

    Assessed after T2 = week 6

  • +1 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention group: receives the HOP program consisting of four 2-hour sessions divided between week 1, week 2, week 3 and week 6, in groups of 4-10 participants, using a Norwegian adaptation of HOP workbook. The intervention group also receives treatment as usual, consisting of weekly or monthly appointments with a mental health care professional at an outpatient unit in the public mental health care service. The appointments can involve medication management, psychoeducation, support therapy or psychotherapy.

Behavioral: Honest Open Proud program

Waiting list control group

NO INTERVENTION

Waiting list control group: receives only treatment as usual, consisting of weekly or monthly appointments with a mental health care professional at an outpatient unit in the public mental health care service. The appointments can involve medication management, psychoeducation, support therapy or psychotherapy. They are offered the HOP program after the trial.

Interventions

The HOP program involves peer facilitated sessions, in which different stigma and disclosure related topics are introduced to the group, relevant tasks are completed individually, followed by group or two-and-two discussions related to the following topics: week 1 = pros and cons with disclosure, week 2 = different ways of disclosing, week 3 = formulating individual decisions of disclosure, week 6 = evaluating disclosure or non-disclosure in practice.

Also known as: Coming Out Proud (COP)
Intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to International Classification of Diseases 10th Revision (ICD-10)
  • Age 18 to 65
  • Ability to provide written informed consent.
  • Fluent in Norwegian (needed for self-report measures)
  • Experience difficulties with stigma and disclosure regarding mental illness.

You may not qualify if:

  • Intellectual disability
  • Organic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Nydalen DPS, Division of Mental Health and Addiction, Oslo University Hospital

Oslo, 0351, Norway

RECRUITING

Søndre Oslo DPS, Division of Mental Health and Addiction, Oslo University Hospital

Oslo, 1281, Norway

NOT YET RECRUITING

Related Links

MeSH Terms

Conditions

Psychotic DisordersBipolar DisorderMental Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersBipolar and Related DisordersMood Disorders

Study Officials

  • Carmen Simonsen, PhD

    Department of Psychology, University of Oslo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sindre Hembre Kruse, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 22, 2024

First Posted

April 25, 2024

Study Start

April 20, 2024

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

May 2, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

The study protocol can be shared, but not the the actual data.

Locations